Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine for hospitalized adults with COVID-19
ChiCTR2000029542Phase 4Recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of chloroquine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoints: viral negative-transforming time and 30-day cause-specific mortality. Started Feb 2020; status: recruiting.
02
Drugs
chloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2000029542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029542.